Sebi rejects Danny Gaekwad's application for competing open offer for Religare Enterprises, citing lack of financial proof.

Sebi has ruled that Gaekwad’s competing bid for Religare was not financially credible and violated regulatory timelines, ...

Gaekwad had requested Sebi's exemption under takeover rules to propose ₹275 a share for Religare, offering a 17% premium to ...

The applicant (Danny Gaekwad Developments & Investments, Florida) has failed to demonstrate his ability to meet the financial ...

SEBI rejects Gaekwad's plea for competing open offer, solidifying Burman Group's acquisition bid for Religare Enterprises.

The Securities and Exchange Board of India (SEBI) on Friday rejected a request from US-based businessman Danny Gaekwad to ...

Sebi rejected Digvijay Gaekwad's competing open offer for Religare Enterprises, citing lack of financial ability and ...

In this week's newsletter, also read about Ameera Shah, executive chairperson of Metropolis Healthcare's views on gender ...

New Delhi, Feb 14 (PTI) Capital markets regulator Sebi on Friday dismissed an application filed by Digvijay Laxhamsinh ...

In order to protect the interests of the shareholders of the target company, Bhatia disposed of the February 1 application of ...

Sebi has returned a letter from US based investors Digvijay Laxmansinh Gaekwad and Danny Gaekwad Developments & Investments, Florida which sought the market regulator's approval to submit a competing ...

Sebi has rejected Digvijay Gaekwad's application to make a competing offer for Religare Enterprises, citing insufficient ...